Immunocore Holdings Plc Adr (IMCR)

Mar 12, 2025

Immunocore’s SWOT analysis: biotech firm’s stock outlook amid HIV and cancer drug progress - Investing.com

Mar 12, 2025

Mar 11, 2025

BTIG maintains Immunocore stock Buy rating, $91 target - Investing.com

Mar 11, 2025

Mar 11, 2025

Immunocore stock hits 52-week low at $27.59 amid market challenges - Investing.com

Mar 11, 2025

Mar 10, 2025

Immunocore reports promising HIV trial results By Investing.com - Investing.com South Africa

Mar 10, 2025

Mar 10, 2025

Immunocore reports promising HIV trial results - Investing.com

Mar 10, 2025

Mar 10, 2025

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 - GlobeNewswire Inc.

Mar 10, 2025

Mar 06, 2025

Immunocore at TD Cowen Conference: Strategic Growth and Innovation - Investing.com India

Mar 06, 2025

Mar 06, 2025

Immunocore at TD Cowen Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa

Mar 06, 2025

Feb 26, 2025

Earnings call transcript: Immunocore Holdings Q4 2024 misses EPS - Investing.com

Feb 26, 2025

Feb 26, 2025

Immunocore Holdings earnings missed by $0.23, revenue fell short of estimates - Investing.com

Feb 26, 2025

Feb 18, 2025

Immunocore Gears Up to Report Q4 Earnings: Is a Beat in Store? - MSN

Feb 18, 2025

Feb 17, 2025

A stock that deserves closer examination: Empresa Distribuidora y Comercial Norte S.A. ADR (EDN) - US Post News

Feb 17, 2025

Feb 17, 2025

I-Mab ADR (IMAB) stock analysis: A simple moving average approach - US Post News

Feb 17, 2025

Feb 17, 2025

A closer look at Inhibrx Biosciences Inc (INBX)’s stock price trends - US Post News

Feb 17, 2025

Jan 13, 2025

Wall Street Analysts Believe Immunocore (IMCR) Could Rally 113.13%: Here's is How to Trade - Yahoo Finance

Jan 13, 2025

Dec 27, 2024

Puma Biotechnology Stock Rises 24% in 3 Months: Here's Why - Zacks Investment Research

Dec 27, 2024

Dec 26, 2024

3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2025 - Yahoo Finance

Dec 26, 2024

Dec 24, 2024

BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer - Yahoo Finance

Dec 24, 2024

Dec 23, 2024

Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term - Yahoo Finance

Dec 23, 2024

Dec 13, 2024

Disappointing data leads to Immunocore stock downgrade by Morgan Stanley - Investing.com South Africa

Dec 13, 2024

Dec 13, 2024

Immunocore stock hits 52-week low at $29.23 amid market challenges - Investing.com

Dec 13, 2024

Dec 13, 2024

Immunocore's SWOT analysis: TCR pioneer's stock faces pivotal year - Investing.com

Dec 13, 2024

Dec 12, 2024

All You Need to Know About Immunocore (IMCR) Rating Upgrade to Strong Buy - Yahoo Finance

Dec 12, 2024

Dec 12, 2024

CORT's Dazucorilant Fails to Meet Goal in Neurologic Disorder Study - Yahoo Finance

Dec 12, 2024

Dec 12, 2024

New Strong Buy Stocks for December 12th - Yahoo Finance

Dec 12, 2024

Dec 09, 2024

Incyte's Late-stage NSCLC Study Meets Primary and Secondary Goals - Yahoo Finance

Dec 09, 2024

Dec 04, 2024

RZLT Stock Rises On FDA's Orphan Designation For Rare Disease Drug - Barchart

Dec 04, 2024

Dec 03, 2024

SNTI Stock Skyrockets On Initial Data From Phase I Cancer Study - Barchart

Dec 03, 2024

Dec 02, 2024

Altimmune Stock Up More Than 25% In A Month: Here's Why - Barchart

Dec 02, 2024

Nov 29, 2024

Does Immunocore (IMCR) Have the Potential to Rally 112.82% as Wall Street Analysts Expect? - MSN

Nov 29, 2024

Nov 29, 2024

Mirum Shares Surge More Than 90% in 6 Months: Here's Why - Yahoo Finance

Nov 29, 2024

Nov 26, 2024

Wall Street Analysts Predict an 112.56% Upside in Immunocore (IMCR): Here's What You Should Know - MSN

Nov 26, 2024

Nov 26, 2024

New Strong Buy Stocks for November 26th - Yahoo Finance

Nov 26, 2024

Nov 20, 2024

Stack Capital Group announces normal course issuer bid - MSN

Nov 20, 2024

Nov 19, 2024

FATE Presents Encourgaing Data From Lupus Study, Stock Gains - Barchart

Nov 19, 2024

Nov 19, 2024

Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study - Nasdaq

Nov 19, 2024

Nov 19, 2024

What will it take for small caps to finally outperform large caps on earnings, performance? - MSN

Nov 19, 2024

Nov 17, 2024

Immunocore (IMCR) Upgraded to Buy: Here's Why - MSN

Nov 17, 2024

Nov 13, 2024

Immunocore's SWOT analysis: biotech stock faces pivotal moment amid PRAME data - Investing.com India

Nov 13, 2024

Nov 13, 2024

FATE Q3 Earnings Beat On Higher Revenues, Pipeline In Focus - Barchart

Nov 13, 2024

Nov 13, 2024

SpringWorks' Q3 Loss Narrower Than Expected, Revenues Miss Mark - Barchart

Nov 13, 2024

Nov 12, 2024

Mirum's Q3 Earnings Beat Estimates, 2024 Revenue View Raised - Barchart

Nov 12, 2024

Nov 11, 2024

Mizuho downgrades Immunocore stock to Neutral, slashes PT to $38 from $72 - Investing.com

Nov 11, 2024

Nov 11, 2024

Rocket Pharmaceuticals' Q3 Earnings Beat, Pipeline In Focus - Barchart

Nov 11, 2024

Nov 09, 2024

Immunocore repays Pharmakon loan, ends agreement - Investing.com India

Nov 09, 2024

Nov 08, 2024

PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up - Barchart

Nov 08, 2024